0% found this document useful (0 votes)
10 views14 pages

Understanding Severe Acute Respiratory Syndrome

Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
10 views14 pages

Understanding Severe Acute Respiratory Syndrome

Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

 Definition:

 Severe acute respiratory syndrome (SARS) is a


communicable viral disease, caused by a new
strain of coronavirus, which differs considerably
in genetic structure from previously recognized
coronavirus.
 Highly contagious atypical pneumonia
 Transmission: primarily through droplet infection,
surface contamination & Airborne.
 Incubation period is 2 - 10 days.
 Epidemiological Patterns:
• First reported in February 2003 in
Asia through a major outbreak
• No outbreak of SARS seen after that
through other forms such as MERS
(Middle East Respiratory Syndrome)
seen.
Cumulative number of cases of SARS and deaths globally and in Asian-Pacific
Region, November , 2002—August 7, 2003
Host (pt)
Age, Medical Conditions,
occupation

Environmental factors Agent


Cold, weather, Crowdedness, SARS-COV-1
sanitation
 Host:
• Genetically: HLA was identified to be correlated to SARS
susceptibility.
• Age : Higher incidence was seen among older age group (
>60 yrs.).
• Sex : Male were more likely to be affected.
• Behavior: Smoking.
• Occupation: Health workers at more risk.
• Residency: Endemic area.
• Comorbid disease associated with high mortality rate.
• Variation in host response to infection.
 Agent:
• SARS Coronavirus (SARS-CoV).
• Is RNA virus of coronaviridae family.

 Environment:
• Overcrowdings
 Primary prevention:
 Health education
 Personal protective measures
 Immunization
 Role and regular polices
 Regular medical examination
 Secondary prevention:
 Screening through case definition and Investigations
 Diagnosis and treatment
 Tertiary prevention:
 Disability and rehabilitation
 Toward the patient:
 Surveillance
 Notification
 Isolation
 Diagnosis And treatment
 Toward at risk population:
 Screening
 Vaccination
 Toward population:
 Vaccination
 Study and survey
 Toward environment:
 Environmental sanitation
Etiology and Transmission
- Etiological agent: SARS Corona ( SARS-CoV)
- Transmission: primarily through droplet infection
.Other source: surface contamination and Air_borne
- Incubation period is 2 - 10 days
Pathophysiology, Clinical features and Diagnosis
- Pathophysiology: complex processes leading to degradation of
organs
* primary target : lungs and intestines ( epithelial cells, villi,
alveolli)
* Immune system: sever lymphocyte depletion
- Clinical features: fever,myalgia,headache,dry non-productive
cough,
others: Diarrhea(25%), shortness of breath, hypoxemia
- Diagnosis: CXR, pulse oximetry, blood culture, sputum gram
stain and culture, ....etc.
- Treatment: supportive care, infection control measures and broad-
spectrum antibiotics.
- Complications: risk of co-infection, comrbidities, respiratory
failure.
* Most cases occurred in :
• China
• Taiwan
• Canda
• Singapore
• Vietnam
• Philippines
• Some parts of Europe

Boulos International Journal of Health Geographics 2004

You might also like